Related Experiment Video

Updated: May 2, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.3K

[Reamberin optimizes drug therapy in children with acute Epstein-Barr viral infection]

E B Kasymova, O A Bashkina, Kh M Galimzianov

    Eksperimental'Naia I Klinicheskaia Farmakologiia
    |March 22, 2014
    PubMed

    Insights

    Reamberin infusion therapy in children with acute Epstein-Barr virus infection significantly reduced fever duration and improved metabolic shifts. This treatment offers faster symptom relief and better recovery compared to standard care.

    Area of Science:

    • Pediatrics
    • Virology
    • Pharmacology

    Context:

    • Acute Epstein-Barr virus (EBV) infection in children presents with significant morbidity.
    • Current treatment protocols involve supportive care and management of symptoms.
    • Investigating novel therapeutic agents for EBV infection is crucial.

    Purpose:

    • To evaluate the efficacy of a 1.5% reamberin solution as part of complex infusion therapy for pediatric acute Epstein-Barr virus infection.
    • To assess reamberin's impact on the inflammatory process, clinical symptoms, and metabolic parameters in children with EBV infection.

    Summary:

    • A 1.5% reamberin solution was administered as part of complex infusion therapy to children with acute Epstein-Barr virus infection.
    • Patients receiving reamberin showed faster relief of general symptoms, improved overall condition, and a shorter febrile period compared to control groups.
    • Reamberin administration facilitated the early resolution of metabolic disturbances, indicated by improved liver protein synthesis function.

    Impact:

    • Reamberin demonstrates potential as an effective adjuvant therapy for acute Epstein-Barr virus infection in children.
    • The study highlights reamberin's beneficial effects on reducing inflammation and accelerating recovery.
    • Findings suggest reamberin can improve clinical outcomes and metabolic status in pediatric EBV patients.

    More Related Videos

    An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection09:43

    An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

    Published on: March 30, 2018

    8.5K
    Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

    Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

    Published on: May 27, 2011

    18.4K

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    408
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    410
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    967
    Acute Pharyngitis01:30

    Acute Pharyngitis

    Introduction
    Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
    Classification
    Acute pharyngitis can be categorized based on its underlying cause:
    6.6K
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    554
    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
    58